Vendor Intelligence Report: Amino Lair

Executive summary

Across 16 Finnrick lab tests, Amino Lair’s current feed shows a 94% overall pass rate (15 pass / 0 fail). The positive case is narrow: Tirzepatide and Retatrutide both test strongly under Finnrick’s public methodology, while the rest of the catalog is not validated by that record. Stricter dose-accuracy views also weaken a simple “broad pass” interpretation.

Amino Lair looks disrupted, not proven abandoned. The Shopify storefront was unavailable, a current GLP-1 Forum thread was inaccessible, and the original Reddit account was permanently banned; meanwhile Telegram @aminolair, a continuity Reddit account, and the domain registration remained alive. The surviving order routes are less auditable than the public storefront/forum layer buyers used for claims, complaints, and corrections.

The identity and geography trail is the real hook. US-domestic forum marketing sits beside retained Shopify evidence of EUR pricing, Spain settings, EU-only shipping language, and a Benidorm legal-notice address with no named legal entity. Delaware registry work came back negative for the Amino Lair/Amino Fitness lead, while the privacy-shielded domain and unresolved Amino Fitness name leave accountability unsettled.

Quality transparency is split the same way. Current Finnrick data supports the two tested GLP-1s, but the report tracks a public NAD+ formulation dispute, Amino Lair’s stated rejection of batch numbers as useful traceability, and a Janoshik vendor-name search with no public Amino Lair COAs. Treat the GLP-1 evidence as product-specific, not transferable.

Inside the full report:

• Appendix A Finnrick Laboratory Data, including product-level pass/fail detail and methodology-divergence charts for both covered products
• Disruption timeline covering Shopify downtime, forum access loss, active Telegram, Reddit ban/continuity, and domain status
• Domain and storefront evidence: Tucows privacy WHOIS, Shopify Shop ID, Spain/EUR configuration, and EU-only shipping captures
• Identity trail for Lex/Lexi, Amino Fitness, Delaware registry dead end, and the Benidorm address match
• Traceability and COA analysis covering batch-number statements, Janoshik search results, NAD+ dispute record, and endotoxin-verification gap
• Promotion-network scan covering Reddit owner/partner signals, the SOLUTION 25 code, and negative X/coupon-site findings

Risk assessment

• Platform-disruption and private-channel recourse risk — high: All products: aminolair.com was unavailable and GLP-1 Forum thread 14276 inaccessible on 2026-07-02 while ordering continuity moved to Telegram/Reddit/private channels.
• NAD+ formulation and labeling injury risk — high: NAD+: retained forum record alleges buffered/unbuffered mismatch with injection-site injury; no public recall/correction located.
• Non-GLP-1 catalog and lot-COA traceability risk — medium: Products outside Tirzepatide/Retatrutide lack Finnrick support; vendor rejects batch numbers and Janoshik search found no public Amino Lair COAs.
• Corporate identity and address-accountability risk — medium: All products: no owner/legal entity verified; Delaware search negative and retained Spain address matches hotel-related address evidence.
• Brand-confusion and channel-verification risk — medium: All products: Amino Lair/Amino Fitness plus Telegram, Signal, Reddit, forum, and a down domain appear without official channel/reseller/anti-counterfeit controls.
• Dose-accuracy / methodology-sensitivity risk — medium: Tirzepatide and Retatrutide: both pass public Finnrick methodology, but stricter methodology views weaken a simple broad-pass read.
• Affiliate-promotion disclosure risk — medium: Reddit promotion: one code-bearing promoter and owner/partner-signal referral activity were captured without clear advertising disclosures.
• Endotoxin-verification gap — medium: All injectable products: supplied public data does not establish routine endotoxin/pyrogen testing across Amino Lair vials.